|
Beyond LDL-C: The Value of Measuring Other Atherogenic Lipoproteins & Markers of Atherogenic Risk
|
 |
Event Overview
This CME presentation reviews the available measurement techniques to assess the risk associated with LDL cholesterol and LDL particles that can be obtained from the traditional lipid profile (calculated LDL-cholesterol, triglycerides, non-HDL-cholesterol), apolipoprotein B and what has been termed "advanced lipoprotein testing". LDL size and density can be measured by at least three available techniques, but generally those measurements do not provide incremental prognostic information on top of non-HDL-cholesterol. In most studies of persons with elevated triglyceride levels, apoB and non-HDL-cholesterol outperform LDL-C as a predictor of future events and as an index of residual risk, with apo B being the best predictor of all the lipid parameters. LDL particle number can be measured more accurately by measuring apo B or by nuclear magnetic resonance than it can by the standard lipid profile. This presentation aims to summarize the available evidence regarding lipid measurement and risk prediction. |
Event Date
Wednesday, 11/4/2009 8:00 AM
|
Event Address
Piedmont Hospital
1968 Peachtree Road, NW
Atlanta, GA 30309
Map |
Contact
To contact the event organizer for questions regarding this event, please click here.
|
|
|
|
|
